Home/AI Tools/AQEMIA

AQEMIA

AI for rapid drug discovery.
General Information
Founders:
Emmanuelle Rolland-Martiano, Maximilien Levesque
Founded Date:
2019-06-13
Total Funding Amount:
64102027
Headquarters Region:
European Union (EU), Europe, Middle East, and Africa (EMEA)
Domain Rating:
37
Organic Traffic:
681
Last Equity Funding Amount:
32529035
Last Equity Funding Date:
2024-01-30
Last Equity Funding Type:
Series A

Overview

Aqemia utilizes AI-driven simulation for accelerating drug discovery, targeting pharmaceutical companies and researchers.

Key Features

AI-based drug design, molecular simulation, predictive modeling.

Pros

Speeds up drug discovery process, enhances molecular design accuracy, integrates seamlessly with existing research workflows.

Cons

Requires significant initial data input, high computational demands.

bg

Get Exclusive Content
Straight to Your Inbox

Subscribe to our [A] Growth Newsletter

More AI tools like this